Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab

Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab

Objective: To examine associations of body mass index (BMI), subcutaneous fat area (SFA) and density (SFD), visceral fat area (VFA) and density (VFD) and total psoas area (TPA) to outcomes among patients receiving chemotherapy with or without bevacizumab for advanced or recurrent endometrial cancer...

Full description

Bibliographic Details
Main Authors: J. Gillen, K.A. Mills, J. Dvorak, B. Zheng, T. Thai, R. Salani, C.M. Cosgrove, B. Davidson, P.H. Thaker, K.N. Moore
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Gynecologic Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2352578919300918

Similar Items

Similar Items